Lucintel Forecasts Liquid Biopsy Market To Reach $9.3 Billion By 2026

By Author: Lucintel LLC
Total Articles: 4081
Comment this article

According to the recent study the liquid biopsy market is projected to reach an estimated $9.3 billion by 2026 from $3.6 billion in 2020, at a CAGR of 17% from 2020 to 2026. Growth in this market is primarily driven by increasing prevalence of cancer, preference for non-invasive procedures and increasing need of early detection of high precision diseases in real time.
Browse 163 figures / charts and 129 tables in this 201 -page report to understand trends, opportunities and forecast in liquid biopsy market by product (assay kits, instruments, and services), circulating biomarker (circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other biomarkers), application (oncology and non-cancer liquid biopsies), clinical application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring) end user (reference laboratories, hospitals and physician laboratories, academic and research centers, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Download sample report and view detailed ...
... Table of Content by clicking on below link https://www.lucintel.com/liquid-biopsy-market.aspx
“Circulating tumor DNA market is expected to remain the largest segment during the forecast period.”
Based on circulating biomarker, the liquid biopsy market is segmented into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other biomarkers. Lucintel forecasts that the circulating tumor DNA (ctDNA) market is expected to remain the largest segment and expected to experience the highest growth during the forecast period due to increasing use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for detecting disease in real time and in early stage.
“Within the liquid biopsy market, the therapy selection segment is expected to remain the largest clinical application”
Based on clinical application, the therapy selection segment is expected to witness the largest clinical application during the forecast period due to its offerings of various benefits such as non-invasiveness, access to tumor heterogeneity, real-time treatment monitoring, and recurrence detection in advance of significant tumor formation or metastasis.
“Asia pacific will dominate the liquid biopsy market in near future”
Asia Pacific is expected to be the largest region with the highest growth over the forecast period due to rising non-invasive treatment, a rising incidence of cancer, and improving healthcare infrastructure.
Download Brochure of this report by clicking on https://www.lucintel.com/liquid-biopsy-market.aspx
Major players of liquid biopsy market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Guardant, Bio-Rad Laboratories, Qaigen, MDxHealth, Myraid, Biocept, Roche, Illumina, and Thermofisher are among the major liquid biopsy providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/liquid-biopsy-market.aspx Or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Global Diagnostic Imaging Market:
For more details click here https://www.lucintel.com/diagnostic-imaging-market.aspx

Medical Battery Market Report:
For more details click here https://www.lucintel.com/medical-battery-market.aspx

Medical Device Market Report:
For more details click here https://www.lucintel.com/medical-device-market.aspx

Wheelchair Market Report:
For more details click here https://www.lucintel.com/wheelchair-market.aspx

Interventional Cardiology and Peripheral Vascular Device Market Report:
For more details click here https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx

Stretcher Market Report:
For more details click here https://www.lucintel.com/stretcher-market.aspx

Stent Market Report:
For more details click here https://www.lucintel.com/stents-market.aspx

Medical Lifting Sling Market Report:
For more details click here https://www.lucintel.com/medical-lifting-sling-market.aspx

3D Printing Medical Device Market Report:
For more details click here https://www.lucintel.com/3d-printing-medical-device-market.aspx

Hand Sanitizer Market Report:
For more details click here https://www.lucintel.com/hand-sanitizer-market.aspx